Clinical Trials Logo

Clinical Trial Summary

The activation of the renin-angiotensin-aldosterone system (RAAS) plays a key role in uncontrolled hypertension or resistant hypertension. Surgery and and medicine are the main treatment for primary aldosteronism(PA) by the current guidelines. However, only a small part of patients with PA meet the surgical criteria, and most of patients with uncontrolled hypertension and activation of RAAS have to take spironolactone or other antihypertensive drugs for long time. On the other side, long-term inhibition of aldosterone receptor may cause hyperkalemia, male breast hyperplasia and other adverse reactions. Moreover, hyperaldosterone is still not corrected by spironolactone, which causes extensive cerebrovascular damages even though blood pressure and blood potassium had been normalized.

With the development of adrenal vein sampling and adrenal ablation, selective arterial ablation of adrenal gland(AAA) was observed with significant decrease of blood aldosterone and blood pressure in patients with PA, which made it promising that uncontrolled hypertension could be relieved by selective AAA.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03660397
Study type Interventional
Source Third Military Medical University
Contact
Status Recruiting
Phase Phase 3
Start date August 1, 2018
Completion date January 1, 2020

See also
  Status Clinical Trial Phase
Withdrawn NCT01939392 - Rapid Renal Sympathetic Denervation for Resistant Hypertension II Phase 2/Phase 3
Terminated NCT01966952 - Evaluation of Safety Mechanisms of Renal Radioablation(RSRA)for Uncontrolled Hypertension N/A
Completed NCT01699529 - Multi-electrode Radiofrequency Renal Denervation System Feasibility Study N/A
Completed NCT01418261 - SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension N/A
Completed NCT01635998 - Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation N/A
Completed NCT02674464 - Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project) N/A
Completed NCT04809519 - Integrative Nursing Based Multimodal Interventions for Uncontrolled Hypertensives N/A
Completed NCT01996033 - EnligHTN German Observational Study of Renal Denervation for Uncontrolled Hypertension
Terminated NCT01628198 - Impact of Renal SympAthetic DenerVation on Chronic HypErtension N/A
Recruiting NCT03221114 - Positive Psychology Intervention for Spanish-speaking Hispanic/Latino Adults at Risk for Cardiovascular Disease N/A
Completed NCT04248530 - DENEX Renal Denervation in Patients With Uncontrolled Hypertension: Safety Study N/A
Recruiting NCT06034743 - A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension Phase 3
Completed NCT02006758 - Observational Study of the EnligHTN Renal Denervation System in Europe
Active, not recruiting NCT03209154 - An Interventional Multidisciplinary Approach to Individualize Blood Pressure Treatment N/A
Withdrawn NCT05352425 - Effect of the MobiusHD® in Renal Hemodialysis Subjects With Uncontrolled Hypertension N/A
Completed NCT05395403 - Use of Automated Office Blood Pressure Monitoring N/A
Recruiting NCT05732727 - Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease Phase 3
Completed NCT02418091 - Integrated Population Program for Diabetic Kidney Disease N/A
Not yet recruiting NCT05234788 - Renal Artery DenervatIon Using Radial accesS in Uncontrolled HyperTensioN N/A
Completed NCT00888433 - Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2) N/A